Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207.

2.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN.

Ann Intern Med. 2018 Aug 21. doi: 10.7326/M18-1136. [Epub ahead of print] No abstract available.

PMID:
30140853
3.

Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.

Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

Drug Alcohol Depend. 2018 Oct 1;191:86-90. doi: 10.1016/j.drugalcdep.2018.06.028. Epub 2018 Jul 31.

4.

Second-generation anti-depressants and risk of new-onset seizures in the elderly.

Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN.

Clin Toxicol (Phila). 2018 Jul 10:1-6. doi: 10.1080/15563650.2018.1483025. [Epub ahead of print]

PMID:
29989445
5.

Depression in Chronic Pain: Might Opioids Be Responsible?

Mazereeuw G, Sullivan MD, Juurlink DN.

Pain. 2018 Jun 13. doi: 10.1097/j.pain.0000000000001305. [Epub ahead of print] No abstract available.

PMID:
29905651
6.

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride.

Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMC Musculoskelet Disord. 2018 May 22;19(1):160. doi: 10.1186/s12891-018-2076-9.

7.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.

Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T.

Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.

8.

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

J Addict Med. 2018 Apr 25. doi: 10.1097/ADM.0000000000000412. [Epub ahead of print] No abstract available.

PMID:
29697503
9.

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study.

Tadrous M, Brahmania M, Martins D, Knowles S, Janssen HLA, Mamdani MM, Juurlink DN, Gomes T.

J Manag Care Spec Pharm. 2018 May;24(5):464-468. doi: 10.18553/jmcp.2018.24.5.464.

10.

Critiquing the CDC Opioid Guideline: Some Light From the Heat.

Juurlink DN.

Clin Pharmacol Ther. 2018 Jun;103(6):966-968. doi: 10.1002/cpt.1061. Epub 2018 Mar 30.

PMID:
29603206
11.

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.

Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T.

CMAJ Open. 2018 Mar 14;6(1):E132-E138. doi: 10.9778/cmajo.20170132.

12.

Fluoroquinolones and the aorta.

Juurlink DN.

BMJ. 2018 Mar 8;360:k988. doi: 10.1136/bmj.k988. No abstract available.

PMID:
29519782
13.

Argyria caused by chronic ingestion of silver.

Bracey NA, Zipursky JS, Juurlink DN.

CMAJ. 2018 Feb 5;190(5):E139. doi: 10.1503/cmaj.171374. No abstract available.

PMID:
29431112
14.

Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study.

Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T.

Can Urol Assoc J. 2018 Mar;12(3):E142-E145. doi: 10.5489/cuaj.4541. Epub 2017 Dec 22.

15.

Challenges Interpreting Chemoprevention Studies Using Observational Data.

Nayan M, Juurlink DN, Finelli A, Kulkarni G, Hamilton RJ.

J Clin Oncol. 2018 Feb 20;36(6):628-629. doi: 10.1200/JCO.2017.76.1064. Epub 2017 Dec 20. No abstract available.

PMID:
29261441
16.

Medication use and kidney cancer survival: A population-based study.

Nayan M, Juurlink DN, Austin PC, Macdonald EM, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Int J Cancer. 2018 May 1;142(9):1776-1785. doi: 10.1002/ijc.31204. Epub 2018 Jan 3.

PMID:
29226327
17.

Impact of a Graduated Approach on Opioid Initiation and Loss of Earnings Following Workplace Injury: A Time Series Analysis.

Gomes T, Duesburry J, Theriault ME, Bain D, Singh S, Martins D, Juurlink DN.

J Occup Environ Med. 2017 Dec;59(12):1197-1201. doi: 10.1097/JOM.0000000000001187.

18.

Availability of naloxone in Canadian pharmacies:a population-based survey.

Cressman AM, Mazereeuw G, Guan Q, Jia W, Gomes T, Juurlink DN.

CMAJ Open. 2017 Nov 8;5(4):E779-E784. doi: 10.9778/cmajo.20170123.

19.

Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis.

Tan VS, Nash DM, McArthur E, Jain AK, Garg AX, Juurlink DN, Weir MA.

Can J Cardiol. 2017 Nov;33(11):1498-1504. doi: 10.1016/j.cjca.2017.09.003. Epub 2017 Sep 12.

PMID:
29111110
20.

Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma.

Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):59-65.e2. doi: 10.1016/j.anai.2017.08.016. Epub 2017 Oct 3.

PMID:
28986124
21.

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.

Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W.

PLoS Med. 2017 Oct 3;14(10):e1002396. doi: 10.1371/journal.pmed.1002396. eCollection 2017 Oct.

22.

The authors respond to "Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain".

Busse JW, Juurlink DN, Buckley DN, Guyatt GH.

CMAJ. 2017 Oct 2;189(39):E1234-E1235. doi: 10.1503/cmaj.733313. No abstract available.

PMID:
28970263
23.

Rethinking "doing well" on chronic opioid therapy.

Juurlink DN.

CMAJ. 2017 Oct 2;189(39):E1222-E1223. doi: 10.1503/cmaj.170628. Review. No abstract available.

PMID:
28970259
24.

Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada.

Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W.

Drug Alcohol Depend. 2017 Oct 1;179:416-423. doi: 10.1016/j.drugalcdep.2017.07.008. Epub 2017 Aug 5.

PMID:
28867560
25.

Maternal infection can cause spontaneous abortion.

Zipursky JS, Cressman A, Juurlink DN.

CMAJ. 2017 Aug 8;189(31):E1021. doi: 10.1503/cmaj.733203. No abstract available.

26.

Medication use and kidney cancer risk: A population-based study.

Nayan M, Juurlink DN, Austin PC, Macdonald EM, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Eur J Cancer. 2017 Sep;83:203-210. doi: 10.1016/j.ejca.2017.07.001. Epub 2017 Jul 24.

PMID:
28750272
27.

The value of complementing administrative data with abstracted information on smoking and obesity: A study in kidney cancer.

Nayan M, Hamilton RJ, Finelli A, Austin PC, Kulkarni GS, Juurlink DN.

Can Urol Assoc J. 2017 Jun;11(6):167-171. doi: 10.5489/cuaj.4569.

28.

Pregabalin and heart failure: A population-based study.

Ho JM, Macdonald EM, Luo J, Gomes T, Antoniou T, Mamdani MM, Juurlink DN.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1087-1092. doi: 10.1002/pds.4239. Epub 2017 Jun 16.

PMID:
28620909
29.

Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study.

Quinn KL, Macdonald EM, Mamdani MM, Diong C, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Drug Saf. 2017 Oct;40(10):887-893. doi: 10.1007/s40264-017-0552-z.

PMID:
28620871
30.

Critical appraisal of the application of propensity score methods in the urology literature.

Nayan M, Hamilton RJ, Juurlink DN, Finelli A, Kulkarni GS, Austin PC.

BJU Int. 2017 Dec;120(6):873-880. doi: 10.1111/bju.13930. Epub 2017 Jul 7.

PMID:
28608364
31.

Loperamide abuse.

Antoniou T, Juurlink DN.

CMAJ. 2017 Jun 12;189(23):E803. doi: 10.1503/cmaj.161421. No abstract available.

32.

A 1980 Letter on the Risk of Opioid Addiction.

Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN.

N Engl J Med. 2017 Jun 1;376(22):2194-2195. doi: 10.1056/NEJMc1700150. No abstract available.

33.

Clinical Review: Loperamide Toxicity.

Wu PE, Juurlink DN.

Ann Emerg Med. 2017 Aug;70(2):245-252. doi: 10.1016/j.annemergmed.2017.04.008. Epub 2017 May 13. Review.

PMID:
28506439
34.

Comment on Shively et al. "Acute salicylate poisoning: risk factors for severe outcome".

Zipursky J, Juurlink DN.

Clin Toxicol (Phila). 2017 Jul;55(6):609. doi: 10.1080/15563650.2017.1290254. Epub 2017 Feb 17. No abstract available.

PMID:
28489463
35.

Guideline for opioid therapy and chronic noncancer pain.

Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH.

CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. No abstract available.

36.

Opioid Overuse or NSAID Underuse? A Response to the Pain Guide.

Hiremath S, Goldfarb DS, Juurlink DN.

Am J Kidney Dis. 2017 Jun;69(6):865. doi: 10.1053/j.ajkd.2017.02.375. Epub 2017 Apr 25. No abstract available.

PMID:
28454686
37.

Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.

Quinn KL, Macdonald EM, Gomes T, Mamdani MM, Huang A, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Drug Saf. 2017 Sep;40(9):835-840. doi: 10.1007/s40264-017-0539-9.

PMID:
28421551
38.

Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis.

Kwok H, Khuu W, Fernandes K, Martins D, Tadrous M, Singh S, Juurlink DN, Gomes T.

Pain Med. 2017 Jun 1;18(6):1019-1026. doi: 10.1093/pm/pnw351.

PMID:
28340102
39.

Lipophilic β-Blockers and Suicide in the Elderly.

Zipursky JS, Macdonald EM, Luo J, Gomes T, Mamdani MM, Paterson JM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

J Clin Psychopharmacol. 2017 Jun;37(3):381-384. doi: 10.1097/JCP.0000000000000695. No abstract available.

PMID:
28338548
40.

Better Studies Are Needed to Guide Treatment of Carbon Monoxide Poisoning.

Juurlink DN, Buckley NA, Eddleston M.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):694. doi: 10.1164/rccm.201611-2255LE. No abstract available.

PMID:
28248145
41.

Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation.

Antoniou T, Macdonald EM, Yao Z, Hollands S, Gomes T, Tadrous M, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

CMAJ. 2017 Jan 9;189(1):E4-E10. doi: 10.1503/cmaj.160303. Epub 2016 Nov 21.

42.

Overdose Risk in Young Children of Women Prescribed Opioids.

Finkelstein Y, Macdonald EM, Gonzalez A, Sivilotti MLA, Mamdani MM, Juurlink DN; Canadian Drug Safety And Effectiveness Research Network (CDSERN).

Pediatrics. 2017 Mar;139(3). pii: e20162887. doi: 10.1542/peds.2016-2887. Epub 2017 Feb 20.

43.

Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis.

Nayan M, Punjani N, Juurlink DN, Finelli A, Austin PC, Kulkarni GS, Uleryk E, Hamilton RJ.

Cancer Treat Rev. 2017 Jan;52:105-116. doi: 10.1016/j.ctrv.2016.11.009. Epub 2016 Nov 27. Review.

PMID:
27992843
44.

Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada.

Knowles SR, Lee K, Paterson JM, Shah BR, Mamdani MM, Juurlink DN, Gomes T.

Can J Diabetes. 2017 Apr;41(2):138-142. doi: 10.1016/j.jcjd.2016.08.225. Epub 2016 Dec 15.

45.

Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study.

Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Tu JV, Juurlink DN, Chu A, Mamdani MM.

JAMA Intern Med. 2017 Jan 1;177(1):61-66. doi: 10.1001/jamainternmed.2016.6851.

PMID:
27820619
46.

Diabetes and kidney cancer outcomes: a propensity score analysis.

Nayan M, Finelli A, Jewett MA, Juurlink DN, Austin PC, Kulkarni GS, Hamilton RJ.

Endocrine. 2017 Feb;55(2):470-477. doi: 10.1007/s12020-016-1149-5. Epub 2016 Nov 4.

PMID:
27815768
47.

Vasectomy and risk of prostate cancer: population based matched cohort study.

Nayan M, Hamilton RJ, Macdonald EM, Li Q, Mamdani MM, Earle CC, Kulkarni GS, Jarvi KA, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

BMJ. 2016 Nov 3;355:i5546. doi: 10.1136/bmj.i5546.

48.

Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study.

Nayan M, Macdonald EM, Juurlink DN, Austin PC, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Pharmacol Res. 2016 Nov;113(Pt A):468-474. doi: 10.1016/j.phrs.2016.09.027. Epub 2016 Sep 24.

PMID:
27678041
49.

Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

St-Onge M, Anseeuw K, Cantrell FL, Gilchrist IC, Hantson P, Bailey B, Lavergne V, Gosselin S, Kerns W 2nd, Laliberté M, Lavonas EJ, Juurlink DN, Muscedere J, Yang CC, Sinuff T, Rieder M, Mégarbane B.

Crit Care Med. 2017 Mar;45(3):e306-e315. doi: 10.1097/CCM.0000000000002087.

50.

Varenicline and Risk of Self-Harm: A Nested Case-Control Study.

Tadrous M, Martins D, Yao Z, Mamdani MM, Juurlink DN, Gomes T, Antoniou T.

PLoS One. 2016 Sep 23;11(9):e0163681. doi: 10.1371/journal.pone.0163681. eCollection 2016.

Supplemental Content

Loading ...
Support Center